Search - tctmd.com

Displaying 41 - 60 of 177

Sort: Relevancy | Date

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Opinion Off Script

My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration

Benoy Shah, MBBS, MD(Res)

January 24, 2024

News Daily News

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

Todd Neale

January 23, 2024

News Daily News

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Todd Neale

December 29, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Conference News AHA 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

Caitlin E. Cox

November 14, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News Daily News

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

L.A. McKeown

September 26, 2023

Advertisement

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

GDMT Rates Low in HFrEF, Particularly in Women

My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

AHA Selects 2023’s Leading Cardiovascular Research

December 2023 Dispatch for the CV Team

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

What’s Going to Be Hot at TCT 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content